FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Abstract Cisplatin resistance is frequently occurred in ovarian cancer therapy, understanding its regulatory mechanisms is critical for developing novel treatment methods and drugs. Here, we found ovarian cancer patients with low FAM83B levels had shorter survival time, tissues with cisplatin resist...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-01-01
|
| Series: | Oncogenesis |
| Online Access: | https://doi.org/10.1038/s41389-020-00301-y |